Reuptake Inhibition: Many drugs work by binding to transporter proteins on the presynaptic membrane that normally recycle neurotransmitters back into the cell. By blocking these 'pumps,' the drug ensures the neurotransmitter remains in the cleft for a longer duration, repeatedly activating postsynaptic receptors.
Enzyme Inhibition: In synapses where neurotransmitters are broken down by enzymes (like acetylcholinesterase), drugs can inhibit these enzymes to prevent degradation. This results in a persistent signal because the neurotransmitter is not cleared from the receptor sites.
Clearance Dynamics: The speed at which a signal is terminated is just as important as its initiation. Drugs that interfere with clearance mechanisms effectively 'stretch' the duration of a single nerve impulse, leading to prolonged physiological responses.
Agonists (Mimicry): Agonists are molecules that have a similar three-dimensional shape to a specific neurotransmitter, allowing them to bind to and activate the corresponding receptors. This 'tricks' the postsynaptic neurone into initiating a response as if the natural signal were present.
Antagonists (Blocking): Antagonists bind to receptors but do not activate them; instead, they occupy the site and prevent the natural neurotransmitter from binding. This effectively reduces or eliminates the signal transmission at that specific synapse.
Receptor Sensitivity: Chronic exposure to drugs can lead to changes in the number of available receptors (upregulation or downregulation). This is a primary mechanism behind drug tolerance, where more of a substance is required to achieve the same effect over time.
| Feature | Receptor Agonists | Reuptake Inhibitors |
|---|---|---|
| Primary Target | Postsynaptic Receptors | Presynaptic Transporters |
| Mechanism | Mimics the neurotransmitter | Prevents removal of natural signal |
| Dependency | Works even if natural signal is low | Requires natural release to be effective |
| Example Effect | Direct activation of the pathway | Prolonged duration of existing signals |
Identify the Site of Action: When presented with a new drug scenario, first determine if the drug acts on the presynaptic neurone, the synaptic cleft, or the postsynaptic neurone. This distinction dictates the logic of the entire pathway.
Trace the Ion Flow: Always link the drug's effect to specific ion movements. For example, if a drug opens sodium channels, it causes depolarisation; if it opens chloride or potassium channels, it causes hyperpolarisation.
Predict the Net Result: Ask yourself: 'Does this drug make the postsynaptic membrane potential more or less positive?' If it moves toward the threshold, it is stimulatory; if it moves away, it is inhibitory.
Check for Feedback: Remember that the body often tries to compensate for drug effects. If a drug increases neurotransmitter levels, the postsynaptic neurone might reduce its receptor count to maintain balance.
